Abstract:Systemic lupus erythematosus (SLE) is a common autoimmune disease with a complex genetic etiology. In the last 2 years, exciting insights supporting the notion that the interleukin17 (IL-17)–producing Th 17 cell subset exerts proinflammatory activity in the pathogenesis of several autoimmune or allergic diseases, including asthma, atopic dermatitis, rheumatoid arthritis (RA), and SLE, have emerged (1,2). High production of IL-17 is observed in SLE patients, and several compounds targeting IL-17 have demonstrated marked clinical efficacy (1,2). Genetic studies have reproducibly demonstrated an association between susceptibility to RA and polymorphisms of the CCR6 gene, a surface marker for Th17 cells (3,4). However, to date no direct link between CCR6 and SLE has been found from genetic studies, although higher percentages of CCR61 T helper cells were observed in patients with SLE, and especially in those with lupus nephritis (LN), compared to controls (5,6). The current study was undertaken to investigate whether there are any associations between CCR6 polymorphisms and susceptibility to LN. The discovery cohort in this study comprised 500 LN patients (mean 6 SD age 32.0 6 11.5 years; 83.6% female) and 900 unrelated healthy individuals (age 31.5 6 8.4 years; 40.1% female). The replication cohort consisted of 626 LN patients (age 32.5 6 12.8 years; 84.0% female) and 1,932 healthy individuals (age 40.9 6 12.7 years; 47.7% female), as well as 1,063 SLE patients without evidence of renal involvement (age 36.6 6 13.4 years; 90.5% female) as an additional control group. All of the SLE patients met the American College of Rheumatology revised criteria for the disease (7). The study was approved by the medical ethics committee of Peking University, and all subjects provided informed consent. Two intronic single-nucleotide polymorphisms (SNPs), rs3093023 and rs3093024, known to be associated with RA with high association signals (3,4), were selected for study, and genotyping was conducted by TaqMan allele discrimination assay (Applied Biosystems) as previously described (8,9). Direct sequencing was performed in 45 samples that were randomly selected on the basis of rs3093024 genotype (15 subjects with the A/A genotype, 15 with the G/A genotype, and 15 with the G/G genotype) to determine whether rs3093024 could tag the recently identified functional CCR6DNP (a triallelic dinucleotide polymorphism of CCR6) (3). The power of the study was calculated using CaTS (http://www.sph.umich.edu/csg/abecasis/CaTS/). As rs3093023 and rs3093024 are in high linkage disequilibrium (LD) (r 5 0.98), indicating that statistical tests performed on each SNP are highly dependent, no multiple correction was applied. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Statistical analyses were performed with SPSS16.0 software. Functional annotations of variants were obtained from the HaploReg and regulomeDB databases. A total of 5,021 Chinese subjects were included as described above. The call rates for rs3093024 and rs3093023 were 99.82% and 98.94%, respectively. Both SNPs studied were in Hardy-Weinberg equilibrium in patients and controls (P . 0.05). With the expected frequency of the rs3093024 and rs3093023 minor allele (40%), the study had a power of 96– 99% to detect a 1.20-fold increased risk in the discovery and replication cohorts separately and combined. The frequency of the A allele of rs3093024 was significantly higher in patients with LN as compared to healthy controls both in the discovery cohort and in the replication cohort (P 5 1.32 3 10 and P 5 4.15 3 10, respectively) (Table 1).

CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythematosus: a meta-analysis.

[Correlation Between CTLA-4 Gene Polymorphism and Systemic Lupus Erythematosus: a Meta-Analysis].

Cytotoxic T Lymphocyte-Associated Antigen-4 Gene Promoter Polymorphisms in Patients with Systemic Lupus Erythematosus in Southern Chinese Population

Meta-analysis Followed by Replication Identifies Loci in or Near CDKN1B, TET3, CD80, DRAM1, and ARID5B As Associated with Systemic Lupus Erythematosus in Asians.

Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-α signature

CTLA-4 Polymorphisms Associate with Breast Cancer Susceptibility in Asians: a Meta-Analysis.

Association Between Ctla-4 60g/A And-1661a/G Polymorphisms And The Risk Of Cancers: A Meta-Analysis

Association between cytotoxic T lymphocyte antigen-4 +49A/G, −1722T/C, and −1661A/G polymorphisms and cancer risk: a meta-analysis

Genetic Susceptibility to Ulcerative Colitis in the Chinese Han Ethnic Population: Association with Tnf Polymorphisms

CTLA-4 Gene Polymorphisms in Chinese Patients with Ulcerative Colitis.

Association of Variants in CCR6 with Susceptibility to Lupus Nephritis in Chinese

Association of CTLA-4 polymorphisms with hematologic malignancy susceptibility: a meta-analysis

Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis

Association of TNFAIP3 and TNIP1 Polymorphisms with Systemic Lupus Erythematosus Risk: A Meta-Analysis

Meta-analysis on the Correlation Between the Polymorphism of IL-10 Gene Promoter Region-592 (A/C) And-1082 (A/G) and Systemic Lupus Erythematosus

Analysis of Association of Cytotoxic T Lymphocyte-Associated Antigen-4 Gene Promoter Polymorphisms with the Clinical Feathers of Systemic Lupus Erythematosus in Han Nationality Population in South of the Changjiang River

Association Between CTLA-4 Rs231775 Polymorphism and Risk of Colorectal Cancer: a Meta Analysis.

CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis.

[Interactions Between Susceptible Genes and Risk Environmental Factors in Chinese Females with Systemic Lupus Erythematosus].

Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis.

Association of CD40 Gene Polymorphisms With Systemic Lupus Erythematosus and Rheumatoid Arthritis in a Chinese Han Population